AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
26th June 2023 Uncategorised 0The authorisation would include certain patients with refractory generalised myasthenia gravis
More: AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
Source: News
